Amgen Inc. 13D and 13G filings for NewAmsterdam Pharma Company N.V.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-23 4:20 pm Sale |
2024-08-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
AMGEN INC AMGN |
0 0.000% |
-4,910,000 (Position Closed) |
Filing |
| 2022-12-02 06:01 am Purchase |
2022-11-22 | 13G | NewAmsterdam Pharma Company N.V. NAMS |
AMGEN INC AMGN |
4,910,000 6.000% |
4,910,000 (New Position) |
Filing |